Literature DB >> 3301101

The clinical condition of IgA-deficient patients is related to the proportion of IgD- and IgM-producing cells in their nasal mucosa.

P Brandtzaeg, G Karlsson, G Hansson, B Petruson, J Björkander, L A Hanson.   

Abstract

Nasal biopsy specimens from 15 adult patients with selective IgA deficiency but normal IgG-subclass levels were examined by immunohistochemistry for the presence of immunocytes producing various Ig isotypes. The mucosal samples were completely IgA-deficient except in two cases where 0.9% and 8.4% IgA cells were found, respectively (normal, 69.8%). Numerous IgG- (mainly IgG1-) producing cells were present in 10 samples; in five of these there were additional IgM- but virtually no IgD-producing cells, whereas in the other five a marked dominance of the IgD over the IgM isotype was seen. The latter category of patients had more upper airways infections (recurrent acute rhinosinusitis, otitis media, and tonsillitis) than the former, who had no recurrent upper respiratory tract infections except one patient with recurrent acute rhinosinusitis. The five remaining samples, which contained very few Ig-producing cells, were derived from patients with even more frequent infections than those showing IgD predominance. Our results indicate that IgM acts as a compensatory secretory Ig in the upper respiratory tract of some IgA-deficient subjects. However, immunoregulatory events favouring local IgD responses apparently do not support mucosal defence satisfactorily, either because local production of IgM is hampered or because IgD (which is not a secretory Ig) blocks complement-dependent reactions mediated by IgG and IgM antibodies within the mucosa.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3301101      PMCID: PMC1542640     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  The human secretory immune system shows striking heterogeneity with regard to involvement of J chain-positive IgD immunocytes.

Authors:  P Brandtzaeg; S T Gjeruldsen; F Korsrud; K Baklien; P Berdal; J Ek
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

2.  Immunoglobulin- and J chain-producing cells associated with lymphoid follicles in the human appendix, colon and ileum, including Peyer's patches.

Authors:  K Bjerke; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

3.  Immunoglobulin systems of human tonsils. I. Control subjects of various ages: quantification of Ig-producing cells, tonsillar morphometry and serum Ig concentrations.

Authors:  P Brandtzaeg; L Surjan; P Berdal
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

4.  The natural antibody response to E. coli includes antibodies of the IgD class.

Authors:  H F Sewell; L Chambers; V Maxwell; J B Matthews; R Jefferis
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

5.  Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus.

Authors:  P L Ogra
Journal:  N Engl J Med       Date:  1971-01-14       Impact factor: 91.245

6.  The induction of immunological tolerance to the parasitic nematode Trichuris muris in cortisone-treated mice.

Authors:  D Wakelin; G R Selby
Journal:  Immunology       Date:  1974-01       Impact factor: 7.397

Review 7.  Role of J chain and secretory component in receptor-mediated glandular and hepatic transport of immunoglobulins in man.

Authors:  P Brandtzaeg
Journal:  Scand J Immunol       Date:  1985-08       Impact factor: 3.487

8.  Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues.

Authors:  K Kett; P Brandtzaeg; J Radl; J J Haaijman
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

9.  Human secretory component--VI. Immunoglobulin-binding properities.

Authors:  P Brandtzaeg
Journal:  Immunochemistry       Date:  1977-03

10.  Crossed immunoelectrophoresis and electroimmunoassay of human IgG subclasses.

Authors:  V A Oxelius
Journal:  Acta Pathol Microbiol Scand C       Date:  1978-06
View more
  33 in total

Review 1.  Diversity of antibody-mediated immunity at the mucosal barrier.

Authors:  J P Bouvet; V A Fischetti
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

2.  Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract.

Authors:  J W Simecka; R J Jackson; H Kiyono; J R McGhee
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 3.  Immunology of the tonsil: a review.

Authors:  G K Scadding
Journal:  J R Soc Med       Date:  1990-02       Impact factor: 5.344

4.  IgD in nasopharyngeal secretions and tonsils from otitis-prone children.

Authors:  C H Sørensen; P L Larsen
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

Review 5.  Microbial-immune cross-talk and regulation of the immune system.

Authors:  Julia Cahenzli; Maria L Balmer; Kathy D McCoy
Journal:  Immunology       Date:  2013-01       Impact factor: 7.397

6.  Reconstituted human polyclonal plasma-derived secretory-like IgM and IgA maintain the barrier function of epithelial cells infected with an enteropathogen.

Authors:  Stéphanie Longet; Cédric Vonarburg; Marius Lötscher; Sylvia Miescher; Adrian Zuercher; Blaise Corthésy
Journal:  J Biol Chem       Date:  2014-06-20       Impact factor: 5.157

7.  Immunity to vaginal HSV-2 infection in immunoglobulin A knockout mice.

Authors:  M B Parr; G R Harriman; E L Parr
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

8.  Ontogenesis of the secretory immune system and innate defence factors in human parotid glands.

Authors:  P S Thrane; T O Rognum; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

Review 9.  Selective IgA deficiency.

Authors:  Leman Yel
Journal:  J Clin Immunol       Date:  2010-01-26       Impact factor: 8.317

Review 10.  Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces.

Authors:  Jiri Mestecky; Michael W Russell
Journal:  Immunol Lett       Date:  2009-04-05       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.